CGEM
Cullinan Therapeutics Inc.
$6.20
-$0.14(-2.21%)
20
Overall
--
Value
10
Tech
31
Quality
Market Cap
$371.58M
Volume
1.20M
52W Range
$5.89 - $18.40
Target Price
$26.88
EPS Estimates Overview
| Current Quarter | $-0.95 | Next Quarter | $-0.91 |
| Current Year | $-3.83 | Next Year | $-3.64 |
| QoQ Growth | +4.2% | YoY Growth | +5.0% |
| 3Y EPS CAGR | +0.0% | Target Price | $26.88 |
| Consensus | Buy | Upside | +333.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CGEM | $6.20 | -2.2% | 1.20M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cullinan Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW